🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT03461237
Recruiting Observational

Chinese Second Hip Fracture Evaluation

NCT03461237 · tracked via the Priya Life Science China tracker
Sponsor
Beijing Jishuitan Hospital
Phase
Observational
Started
2017-05-01
Last updated
2025-08-17

Condition(s) studied

Hip FracturesOsteoporosis

Study summary

1. To Compare overall rates of second hip fractures in both genders,
2. To determine the effect of hip fracture on proximal femoral volumetric bone mineral density (vBMD), bone structure and muscle by quantitative computed tomography(QCT),
3. To evaluate the contribution of QCT-image analysis to the prediction of the second hip fracture risk.
4. To identify the differences between femoral neck fracture and trochanter fracture following hip fracture

Eligibility

Sex
ALL
Min age
50 Years
Max age
95 Years
Healthy volunteers
Accepted
Inclusion Criteria: * a:Osteoporotic patients b:Osteoporotic hip fracture patients (femoral neck fracture and femoral trochanteric fracture) c: Be willing to and be able to join in the study and sighed the informed consent Exclusion Criteria: * a:Under 47years old b:Non-surgical repair of hip fracture c:Pathologic fracture d:Violence-related trauma e:Bilateral hip implants or have hip replacement on the non-fractured side

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Beijing ji shui tan hospital Beijing Beijing Municipality Recruiting

More Beijing Jishuitan Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03461237 on ClinicalTrials.gov ↗ ← All trials in China